Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their.

Slides:

Advertisements

Similar presentations

Water-soluble chitosan inhibits nerve growth factor and attenuates allergic inflammation in mite allergen–induced allergic rhinitis Pei-Chi Chen, MSc,

Advertisements

Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 Natalija Novak, MD, Nihal Mete, MD, Caroline.

Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R

Expression of IL-9 receptor α chain on human germinal center B cells modulates IgE secretion Lama M. Fawaz, PhD, Ehssan Sharif-Askari, PhD, Oumnia Hajoui,

Flow cytometry imaging identifies rare TH2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu Amanda J. Reefer, MS, Kathryn.

Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion Malte Lenders, PhD, Boris Schmitz, PhD, Stefan-Martin.

Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response Miriam Wittmann, MD, Mareike Alter, Tanja.

IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven TH1 differentiation Regina K. Rowe, MD, PhD, David M. Pyle, MD,

Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis Eva Gros, MSc, Susanne Petzold,

Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy Margarete Focke-Tejkl, PhD, Milena.

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3) Aleena.

Protective role of nuclear factor of activated T cells 2 in CD8+ long-lived memory T cells in an allergy model Roman Karwot, PhD, Joachim H. Maxeiner,

Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels Miguel L. Stein, MD, Joyce M. Villanueva,

Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitro Pierre Pochard, PhD, Brian Vickery, MD, M. Cecilia.

Dendritic cells: Bridging innate and adaptive immunity in atopic dermatitis Natalija Novak, MD, Susanne Koch, PhD, Jean-Pierre Allam, MD, Thomas Bieber,

Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II

Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease Kirandeep.

Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin Mohan S. Maddur, DVM, Janakiraman Vani,

Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies

Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells Jean-Pierre Allam, MD, Wen-Ming Peng, MSc, Torsten Appel,

Glucocorticoids promote intrinsic human TH17 differentiation

Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease Kirandeep.

Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers

A Reducing Microenvironment Leads to the Generation of FcεRIhigh Inflammatory Dendritic Epidermal Cells (IDEC) Natalija Novak, MD, Stefan Kraft, Jörg.

Molecular determinants of allergen-induced effector cell degranulation

Tacrolimus and TGF-β act synergistically on the generation of Langerhans cells Bartlomiej Kwiek, MD, Wen-Ming Peng, MSc, Jean-Pierre Allam, MD, Andrzej.

Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease John W. Steinke, PhD, Lixia Liu, MD, Phillip Huyett, MD, Julie Negri,

Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J

Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent Brittany M. Salter, BSc, John Paul Oliveria,

Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen- presenting cells that induce proallergic T cells Susanne Ebner, PhD,

Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,

Targeting allergen to FcγRI reveals a novel TH2 regulatory pathway linked to thymic stromal lymphopoietin receptor Kathryn E. Hulse, PhD, Amanda J. Reefer,

The Human Skin–Associated Autoantigen α-NAC Activates Monocytes and Dendritic Cells via TLR-2 and Primes an IL-12-Dependent Th1 Response Susanne Hradetzky,

Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5 Margarete Focke-Tejkl, PhD, Raffaela Campana, PhD, Renate.

Β2 integrins rather than β1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung Maya R. Karta, PhD, Peter S. Rosenthal,

A thymic stromal lymphopoietin–responsive dendritic cell subset mediates allergic responses in the upper airway mucosa Guro R. Melum, MD, Lorant Farkas,

Role of hyaluronan and hyaluronan-binding proteins in human asthma

Bet v 1–specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1–specific T-cell effector function in an activation-dependent.

Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,

The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells Juha Punnonen, MD, PhD, Hans Yssel, PhD,

Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma Benny Dua, MSc, Richard M. Watson, BSc,

Toward experimental assessment of receptor occupancy: TGN1412 revisited Zoe Waibler, PhD, Linda Y. Sender, Christel Kamp, PhD, Jan Müller-Berghaus, MD,

Expression of IL-9 receptor α chain on human germinal center B cells modulates IgE secretion Lama M. Fawaz, PhD, Ehssan Sharif-Askari, PhD, Oumnia Hajoui,

Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria Thomas Gentinetta, MSc, Tatjana.

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506) Andrea Panhans-Groß, MD, Natalija Novak, MD, Stefan.

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation Abel Suárez-Fueyo, PhD, Tania.

Characterization of FcεRI-bearing CD123+ blood dendritic cell antigen-2+ plasmacytoid dendritic cells in atopic dermatitis Natalija Novak, MD, Jean-Pierre.

Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R

Selection of house dust mite–allergic patients by molecular diagnosis may enhance success of specific immunotherapy Kuan-Wei Chen, PhD, Petra Zieglmayer,

Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children Yvonne Resch, MSc, Sven Michel, MSc, Michael Kabesch, MD,

Substance P represents a novel first-line defense mechanism in the nose Olivia Larsson, PhD, Lotta Tengroth, MSc, Yuan Xu, PhD, Rolf Uddman, MD, PhD,

Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity Iris Bellinghausen, PhD, Sebastian.

Tumor Necrosis Factor-α- and IL-4-Independent Development of Langerhans Cell-Like Dendritic Cells from M-CSF-Conditioned Precursors Jean-Baptiste Barbaroux,

Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P

CD23 surface density on B cells is associated with IgE levels and determines IgE- facilitated allergen uptake, as well as activation of allergen-specific.

Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,

Harald Renz, MD, Chaya Brodie, PhD, Katherine Bradley, BS, Donald Y. M

Impairment of T-regulatory cells in cord blood of atopic mothers

Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis Eva Gros, MSc, Caroline Bussmann,

CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4 Kandace Bonner,

Regulation of IL-13 receptor α1 expression and signaling on human tonsillar B- lymphocyte subsets Oumnia Hajoui, PhD, Huaien Zheng, MD, PhD, Julie Guay,

IL-10–producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients Antje Prasse, MD, Martin Germann,

Päivi M. Salo, PhD, Samuel J. Arbes, DDS, MPH, PhD, Patrick W

The extra domain A of fibronectin is essential for allergen-induced airway fibrosis and hyperresponsiveness in mice Martin Kohan, MSc, Andres F. Muro,

CD11b-mediated migratory property of peripheral blood B cells

Exposure to a farming environment has allergen-specific protective effects on TH2- dependent isotype switching in response to common inhalants Debra A.

Dendritic cells in nasal mucosa of subjects with different allergic sensitizations Susanne M. Reinartz, MD, Joost van Tongeren, MD, Danielle van Egmond,

Characterization of dendritic cells from human oral mucosa: A new Langerhans' cell type with high constitutive FcϵRI expression Jean-Pierre Allam, MDa,

CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4 Kandace Bonner,

Presentation transcript:

Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-β1 and IL-10–producing properties Jean-Pierre Allam, MD, Peter A. Würtzen, PhD, Markus Reinartz, MSc, Jochen Winter, PhD, Susanne Vrtala, PhD, Kuan-Wei Chen, MSc, Rudolf Valenta, MD, Matthias Wenghoefer, MD, DMD, Thorsten Appel, MD, DMD, Eva Gros, MSc, Bernd Niederhagen, MD, DMD, Thomas Bieber, MD, PhD, Kaare Lund, PhD, Natalija Novak, MD Journal of Allergy and Clinical Immunology Volume 126, Issue 3, Pages 638-645.e1 (September 2010) DOI: 10.1016/j.jaci.2010.04.039 Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Allergen exposure for 5 minutes is sufficient to induce Phl p 5 binding to oLCs, and saturation of Phl p 5 binding to oLCs is reached at a dose of 1 mg/mL Phl p 5. A, Oral mucosal tissue was incubated with FITC-coupled Phl p 5 (1 mg/mL) for 20 seconds, 60 seconds, 5 minutes, 10 minutes, and 60 minutes (n = 10) at 37°C and 4°C. Significant binding of Phl p 5 to oLCs could be detected after 5 minutes of allergen exposure (solid black line, circles). oLCs from samples of individuals with GPA (dotted line, squares; n = 5) and nonatopic individuals (NAT; dashed line, triangles; n = 5) displayed comparable dose-dependent binding capacity. ∗P < .05; ∗∗P < .01. Oral mucosal tissue was incubated for 10 minutes with FITC-coupled Phl p 5 (1 mg/mL) at 4°C (B) or FITC-coupled Phl p 5 (1 mg/mL) at 37°C (C) or with pure Phl p 5 (1 mg/mL, 10 minutes) at 37°C before addition of FITC-coupled Phl p 5 (1 mg/mL, 10 minutes) at 37°C (D), and oLCs migrating out of the tissue were analyzed 36 hours after exposure. Values are depicted as means of percent-positive CD1a cells ± SEMs. Preincubation of oral mucosal tissue with pure Phl p 5 at a concentration of 1 mg/mL inhibited binding of FITC-coupled Phl p 5 (1 mg/mL); ∗P < .05 compared with oLCs + FITC–Phl p 5 at 4°C; #P < .05 compared with oLCs + Phl p 5 + FITC–Phl p 5 at 37°C. Figures show representative plots. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Amount of Phl p 5 binding to CD1a+ oLCs is dose-dependent. Oral mucosal tissue was incubated with FITC-coupled Phl p 5 at 4°C (A) and at 37°C (B) for 60 minutes by using 10 μg/mL (first column, n = 10), 100 μg/mL (second column, n = 16), and 1000 μg/mL (third column, n = 10) Phl p 5. Thirty-six hours after allergen exposition, migrated cells were harvested. OLCs were detected by CD1a expression (y-axis) and analyzed for Phl p 5 binding (x-axis). Values are depicted as means of percent-positive CD1a cells ± SEMs (upper right corner of the counter plots). A dose-dependent binding of Phl p 5 to CD1a+ oLCs could be detected. Compared with 10 μg/mL, significant Phl p 5 binding to CD1a+ oLCs could be demonstrated for 100 μg/mL (second column) and 1000 μg/mL (third column) Phl p 5. ∗P < .05. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Percentage of oLCs binding Phl p 5 and emigrating from the tissue remains stable whereas the percentage of migrating oLCs that bound dextran decreases continuously after exposure. Oral mucosal tissue was incubated with FITC-coupled Phl p 5 (100 μg/mL; dark green line, circles) or FITC-coupled dextran (100 μg/mL; gray line, dashed) at 4°C and at 37°C for 60 minutes. Twenty-four, 36, and 48 hours after exposure, migrated cells were harvested while tissue remained in culture. OLCs were detected by CD1a expression and analyzed for Phl p 5 or dextran binding. Specific binding of Phl p 5 was calculated as described in the Methods section. Values are depicted as means of percent-positive CD1a cells ± SEMs. Binding of Phl p 5 to CD1a+ oLCs was stable at all investigated time points, whereas binding of dextran decreased. The strongest binding of dextran could be detected after 24 hours, which was significantly higher than Phl p 5 binding at this time point. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Phl p 5 stimulation enhances migratory capacity of oLCs. Oral mucosal tissue (n = 14) was incubated with FITC-coupled Phl p 5 (100 μg/mL; 60 minutes) at 4°C (black lines, diamond) and at 37°C (red line, triangles) in GPA (A and C) and nonatopic (NAT) samples (B and D), with PBS (60 minutes; gray line, squares; A and B) or with FITC-coupled dextran (100 μg/mL; 60 minutes) at 4°C (60 minutes; black line, diamonds) and at 37°C (gray line, squares; C and D). Twenty-four, 36, and 48 hours after exposure, migrated cells were harvested and tissue was trypsinized and analyzed for oLCs resting in the tissue. oLCs were detected by CD1a expression. A significantly higher percentage of CD1a+ cells migrated out of the oral mucosal tissue 36 and 48 hours after exposure to Phl p 5 at 37°C compared with oLCs incubated with Phl p 5 at 4°C, PBS, or with dextran at 4°C and 37°C. ∗P < .05; ∗∗P < .01. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 CD1a+ oLCs that have taken up Phl p 5 and migrate out of the tissue are retained in an immature state. Oral mucosal tissue was incubated with FITC-coupled Phl p 5 (100 μg/mL; 60 minutes) at 37°C. Thirty-six hours after allergen exposure, migrated cells were harvested. CD1a+ cells were gated manually depending on their Phl p 5 binding (counter plots, upper row). Gated CD1a+ cells were discriminated in CD1a+ without Phl p 5 binding (first column) and with Phl p 5 binding (second column) compared with isotype control (A); expression of CD207, n = 11 (B); CCR6, n = 6 (C); CCR7, n = 6 (D); and CD83, n = 15 (E) was analyzed. Thereby we could detect a comparable expression of CD207 and CCR6 on both populations, clearly identifying CD1a+ as oLCs. Moreover CCR7 and CD83 expression was decreased on Phl p 5–positive oLCs compared with Phl p 5–negative oLCs. ∗P < .05. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Phl p 5 binding to oLCs increases their TGF-β1 and IL-10 production. Oral mucosal tissue was incubated with Phl p 5 (100 μg/mL; 60 minutes) at 4°C and 37°C (n = 17). After migration of oLCs for 3 hours, intracellular staining of CD1a+ cells for TGF-β1 (A) and IL-10 (B) with respective isotype controls (upper row) was performed. A significantly higher production of TGF-β1 and IL-10 could be detected in oLCs, which migrated from tissue incubated with Phl p 5 at 37°C. ∗P < .05. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 7 Phl p 5 binding to oLCs promotesTGF-β1 and IL-10 production of cocultured T cells. T cells were cultured alone (first column), together with oLCs migrated from tissue, which was incubated with Phl p 5 (100 μg/mL) at 4°C (second column) or oLCs migrated from tissue that was incubated with Phl p 5 (100 μg/mL) at 37°C (third column; n = 9). After 5 days of coculture, T cells were detected by CD3 expression (y-axis, zebra plots) and analyzed for expression of TGF-β1 (B) and IL-10 (C) compared with isotype controls (A). T cells cocultured with oLCs from tissue that was previously incubated with Phl p 5 at 37°C produced increased amounts of TGF-β1 and IL-10; ∗P < .05 compared with T cells + oLCs + Phl p 5 (100 μg/mL) at 4°C; #P < .05 compared with T cells alone. Journal of Allergy and Clinical Immunology 2010 126, 638-645.e1DOI: (10.1016/j.jaci.2010.04.039) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions